Copyright
©The Author(s) 2019.
World J Gastroenterol. May 21, 2019; 25(19): 2365-2372
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2365
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2365
Table 3 The performance characteristics of the rate of change of time-intensity curve parameters for the prediction of responders
Slope (95%CI) | TTP (95%CI) | AUC (95%CI) | |
AUROC | 0.818 (0.602-0.944) | 0.869 (0.728-0.975) | 0.939 (0.812-0995) |
Cut-off value (%) | -11.765 | +9.495 | -25.714 |
Sensitivity | 0.889 (0.540-0.978) | 0.889 (0.540-0.978) | 0.896 (0.616-0.989) |
Specificity | 0.545 (0.304-0.786) | 0.818 (0.510-0.917) | 0.909 (0.648-0.995) |
PPV | 0.615 (0.583-0.793) | 0.800 (0.611-0.907) | 0.833 (0.727-0.918) |
NPV | 0.857 (0.731-0.922) | 0.878 (0.741-0.962) | 0.900 (0.747-0.992) |
- Citation: Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2019; 25(19): 2365-2372
- URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2365.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i19.2365